nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2A6—esophageal cancer	0.43	0.729	CbGaD
Cyclophosphamide—ABCB1—esophageal cancer	0.16	0.271	CbGaD
Cyclophosphamide—CYP2C9—Capecitabine—esophageal cancer	0.0285	0.306	CbGbCtD
Cyclophosphamide—CYP2B6—Cisplatin—esophageal cancer	0.0272	0.292	CbGbCtD
Cyclophosphamide—CYP2C9—Cisplatin—esophageal cancer	0.0143	0.154	CbGbCtD
Cyclophosphamide—ABCB1—Cisplatin—esophageal cancer	0.0139	0.15	CbGbCtD
Cyclophosphamide—ABCB1—Methotrexate—esophageal cancer	0.00904	0.0972	CbGbCtD
Cyclophosphamide—Ifosfamide—CYP2A6—esophageal cancer	0.0029	0.566	CrCbGaD
Cyclophosphamide—Ifosfamide—PTGS1—esophageal cancer	0.00222	0.434	CrCbGaD
Cyclophosphamide—Deafness—Cisplatin—esophageal cancer	0.000438	0.00213	CcSEcCtD
Cyclophosphamide—Oropharyngeal pain—Capecitabine—esophageal cancer	0.000438	0.00212	CcSEcCtD
Cyclophosphamide—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000438	0.00212	CcSEcCtD
Cyclophosphamide—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000434	0.00211	CcSEcCtD
Cyclophosphamide—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000432	0.0021	CcSEcCtD
Cyclophosphamide—Lacrimation increased—Capecitabine—esophageal cancer	0.000432	0.0021	CcSEcCtD
Cyclophosphamide—Nasal congestion—Cisplatin—esophageal cancer	0.00043	0.00209	CcSEcCtD
Cyclophosphamide—Renal failure acute—Cisplatin—esophageal cancer	0.000425	0.00206	CcSEcCtD
Cyclophosphamide—Blood bilirubin increased—Capecitabine—esophageal cancer	0.000421	0.00204	CcSEcCtD
Cyclophosphamide—Ulcer—Capecitabine—esophageal cancer	0.000421	0.00204	CcSEcCtD
Cyclophosphamide—Interstitial lung disease—Methotrexate—esophageal cancer	0.000419	0.00203	CcSEcCtD
Cyclophosphamide—Hearing impaired—Capecitabine—esophageal cancer	0.000418	0.00203	CcSEcCtD
Cyclophosphamide—Inflammation—Capecitabine—esophageal cancer	0.00041	0.00199	CcSEcCtD
Cyclophosphamide—Pulmonary embolism—Capecitabine—esophageal cancer	0.000398	0.00193	CcSEcCtD
Cyclophosphamide—Hyponatraemia—Cisplatin—esophageal cancer	0.000394	0.00191	CcSEcCtD
Cyclophosphamide—Herpes zoster—Methotrexate—esophageal cancer	0.000393	0.00191	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000392	0.0019	CcSEcCtD
Cyclophosphamide—Pleural effusion—Methotrexate—esophageal cancer	0.000387	0.00188	CcSEcCtD
Cyclophosphamide—Influenza like illness—Capecitabine—esophageal cancer	0.000387	0.00188	CcSEcCtD
Cyclophosphamide—Hepatotoxicity—Methotrexate—esophageal cancer	0.000384	0.00186	CcSEcCtD
Cyclophosphamide—Colitis—Capecitabine—esophageal cancer	0.000382	0.00186	CcSEcCtD
Cyclophosphamide—Fluid retention—Capecitabine—esophageal cancer	0.000378	0.00183	CcSEcCtD
Cyclophosphamide—Necrosis—Methotrexate—esophageal cancer	0.000378	0.00183	CcSEcCtD
Cyclophosphamide—Mouth ulceration—Capecitabine—esophageal cancer	0.00036	0.00175	CcSEcCtD
Cyclophosphamide—Neoplasm—Capecitabine—esophageal cancer	0.00036	0.00175	CcSEcCtD
Cyclophosphamide—Nasopharyngitis—Cisplatin—esophageal cancer	0.00035	0.0017	CcSEcCtD
Cyclophosphamide—Sepsis—Capecitabine—esophageal cancer	0.000345	0.00168	CcSEcCtD
Cyclophosphamide—Extravasation—Methotrexate—esophageal cancer	0.00034	0.00165	CcSEcCtD
Cyclophosphamide—Phlebitis—Capecitabine—esophageal cancer	0.000335	0.00163	CcSEcCtD
Cyclophosphamide—Diabetes mellitus—Capecitabine—esophageal cancer	0.000332	0.00161	CcSEcCtD
Cyclophosphamide—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000331	0.00161	CcSEcCtD
Cyclophosphamide—Sweating increased—Cisplatin—esophageal cancer	0.00033	0.0016	CcSEcCtD
Cyclophosphamide—Polyuria—Capecitabine—esophageal cancer	0.000329	0.0016	CcSEcCtD
Cyclophosphamide—Swelling—Capecitabine—esophageal cancer	0.000328	0.00159	CcSEcCtD
Cyclophosphamide—Gastroenteritis—Capecitabine—esophageal cancer	0.000326	0.00158	CcSEcCtD
Cyclophosphamide—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000326	0.00158	CcSEcCtD
Cyclophosphamide—Abdominal discomfort—Cisplatin—esophageal cancer	0.000325	0.00158	CcSEcCtD
Cyclophosphamide—Deafness—Capecitabine—esophageal cancer	0.000323	0.00157	CcSEcCtD
Cyclophosphamide—Pancytopenia—Cisplatin—esophageal cancer	0.000322	0.00156	CcSEcCtD
Cyclophosphamide—Hepatic failure—Capecitabine—esophageal cancer	0.000321	0.00156	CcSEcCtD
Cyclophosphamide—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00032	0.00155	CcSEcCtD
Cyclophosphamide—Hyperuricaemia—Methotrexate—esophageal cancer	0.000319	0.00155	CcSEcCtD
Cyclophosphamide—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000313	0.00152	CcSEcCtD
Cyclophosphamide—Ulcer—Methotrexate—esophageal cancer	0.000313	0.00152	CcSEcCtD
Cyclophosphamide—Renal failure acute—Capecitabine—esophageal cancer	0.000313	0.00152	CcSEcCtD
Cyclophosphamide—Hot flush—Capecitabine—esophageal cancer	0.000309	0.0015	CcSEcCtD
Cyclophosphamide—Menopausal symptoms—Capecitabine—esophageal cancer	0.000306	0.00149	CcSEcCtD
Cyclophosphamide—Inflammation—Methotrexate—esophageal cancer	0.000305	0.00148	CcSEcCtD
Cyclophosphamide—Atrial fibrillation—Capecitabine—esophageal cancer	0.000305	0.00148	CcSEcCtD
Cyclophosphamide—Renal impairment—Capecitabine—esophageal cancer	0.000304	0.00147	CcSEcCtD
Cyclophosphamide—Vasculitis—Methotrexate—esophageal cancer	0.000304	0.00147	CcSEcCtD
Cyclophosphamide—Dermatitis bullous—Capecitabine—esophageal cancer	0.000302	0.00147	CcSEcCtD
Cyclophosphamide—Blood uric acid increased—Methotrexate—esophageal cancer	0.000302	0.00146	CcSEcCtD
Cyclophosphamide—Respiratory failure—Methotrexate—esophageal cancer	0.000302	0.00146	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000298	0.00145	CcSEcCtD
Cyclophosphamide—Renal failure—Cisplatin—esophageal cancer	0.000297	0.00144	CcSEcCtD
Cyclophosphamide—Pulmonary embolism—Methotrexate—esophageal cancer	0.000296	0.00144	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000296	0.00144	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Cisplatin—esophageal cancer	0.000296	0.00144	CcSEcCtD
Cyclophosphamide—Cardiac failure—Capecitabine—esophageal cancer	0.000296	0.00144	CcSEcCtD
Cyclophosphamide—Stomatitis—Cisplatin—esophageal cancer	0.000294	0.00143	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Cisplatin—esophageal cancer	0.000294	0.00143	CcSEcCtD
Cyclophosphamide—Hyponatraemia—Capecitabine—esophageal cancer	0.00029	0.00141	CcSEcCtD
Cyclophosphamide—Cystitis noninfective—Methotrexate—esophageal cancer	0.000289	0.00141	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000289	0.0014	CcSEcCtD
Cyclophosphamide—Cystitis—Methotrexate—esophageal cancer	0.000286	0.00139	CcSEcCtD
Cyclophosphamide—Bradycardia—Cisplatin—esophageal cancer	0.000276	0.00134	CcSEcCtD
Cyclophosphamide—Cardiac arrest—Capecitabine—esophageal cancer	0.000275	0.00133	CcSEcCtD
Cyclophosphamide—Bladder pain—Methotrexate—esophageal cancer	0.000268	0.0013	CcSEcCtD
Cyclophosphamide—Mouth ulceration—Methotrexate—esophageal cancer	0.000268	0.0013	CcSEcCtD
Cyclophosphamide—Neoplasm—Methotrexate—esophageal cancer	0.000268	0.0013	CcSEcCtD
Cyclophosphamide—Pulmonary oedema—Methotrexate—esophageal cancer	0.000264	0.00128	CcSEcCtD
Cyclophosphamide—Visual impairment—Cisplatin—esophageal cancer	0.000261	0.00127	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00026	0.00126	CcSEcCtD
Cyclophosphamide—Nasopharyngitis—Capecitabine—esophageal cancer	0.000258	0.00125	CcSEcCtD
Cyclophosphamide—Sepsis—Methotrexate—esophageal cancer	0.000257	0.00125	CcSEcCtD
Cyclophosphamide—Tinnitus—Cisplatin—esophageal cancer	0.000253	0.00123	CcSEcCtD
Cyclophosphamide—Flushing—Cisplatin—esophageal cancer	0.000252	0.00122	CcSEcCtD
Cyclophosphamide—Diabetes mellitus—Methotrexate—esophageal cancer	0.000247	0.0012	CcSEcCtD
Cyclophosphamide—Bronchospasm—Capecitabine—esophageal cancer	0.000246	0.00119	CcSEcCtD
Cyclophosphamide—Polyuria—Methotrexate—esophageal cancer	0.000245	0.00119	CcSEcCtD
Cyclophosphamide—Sweating increased—Capecitabine—esophageal cancer	0.000243	0.00118	CcSEcCtD
Cyclophosphamide—Arrhythmia—Cisplatin—esophageal cancer	0.000242	0.00118	CcSEcCtD
Cyclophosphamide—Alopecia—Cisplatin—esophageal cancer	0.00024	0.00116	CcSEcCtD
Cyclophosphamide—Abdominal discomfort—Capecitabine—esophageal cancer	0.000239	0.00116	CcSEcCtD
Cyclophosphamide—Hepatic failure—Methotrexate—esophageal cancer	0.000239	0.00116	CcSEcCtD
Cyclophosphamide—Pancytopenia—Capecitabine—esophageal cancer	0.000237	0.00115	CcSEcCtD
Cyclophosphamide—Erythema—Cisplatin—esophageal cancer	0.000236	0.00115	CcSEcCtD
Cyclophosphamide—Renal failure acute—Methotrexate—esophageal cancer	0.000233	0.00113	CcSEcCtD
Cyclophosphamide—Weight increased—Capecitabine—esophageal cancer	0.000227	0.0011	CcSEcCtD
Cyclophosphamide—Muscle spasms—Cisplatin—esophageal cancer	0.000227	0.0011	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Capecitabine—esophageal cancer	0.000225	0.00109	CcSEcCtD
Cyclophosphamide—Pneumonia—Capecitabine—esophageal cancer	0.000224	0.00109	CcSEcCtD
Cyclophosphamide—Vision blurred—Cisplatin—esophageal cancer	0.000222	0.00108	CcSEcCtD
Cyclophosphamide—Tremor—Cisplatin—esophageal cancer	0.000221	0.00107	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000221	0.00107	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000219	0.00107	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Cisplatin—esophageal cancer	0.000219	0.00106	CcSEcCtD
Cyclophosphamide—Renal failure—Capecitabine—esophageal cancer	0.000219	0.00106	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Capecitabine—esophageal cancer	0.000218	0.00106	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000218	0.00106	CcSEcCtD
Cyclophosphamide—Anaemia—Cisplatin—esophageal cancer	0.000218	0.00106	CcSEcCtD
Cyclophosphamide—Jaundice—Capecitabine—esophageal cancer	0.000217	0.00105	CcSEcCtD
Cyclophosphamide—Stomatitis—Capecitabine—esophageal cancer	0.000217	0.00105	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Capecitabine—esophageal cancer	0.000216	0.00105	CcSEcCtD
Cyclophosphamide—Malaise—Cisplatin—esophageal cancer	0.000213	0.00103	CcSEcCtD
Cyclophosphamide—Haematuria—Capecitabine—esophageal cancer	0.000212	0.00103	CcSEcCtD
Cyclophosphamide—Leukopenia—Cisplatin—esophageal cancer	0.000211	0.00103	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Capecitabine—esophageal cancer	0.000208	0.00101	CcSEcCtD
Cyclophosphamide—Convulsion—Cisplatin—esophageal cancer	0.000205	0.000993	CcSEcCtD
Cyclophosphamide—Bradycardia—Capecitabine—esophageal cancer	0.000203	0.000988	CcSEcCtD
Cyclophosphamide—Myalgia—Cisplatin—esophageal cancer	0.000201	0.000976	CcSEcCtD
Cyclophosphamide—Haemoglobin—Capecitabine—esophageal cancer	0.000201	0.000975	CcSEcCtD
Cyclophosphamide—Rhinitis—Capecitabine—esophageal cancer	0.0002	0.000973	CcSEcCtD
Cyclophosphamide—Haemorrhage—Capecitabine—esophageal cancer	0.0002	0.00097	CcSEcCtD
Cyclophosphamide—Hepatitis—Capecitabine—esophageal cancer	0.0002	0.00097	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Capecitabine—esophageal cancer	0.000199	0.000965	CcSEcCtD
Cyclophosphamide—Discomfort—Cisplatin—esophageal cancer	0.000199	0.000964	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000194	0.00094	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Cisplatin—esophageal cancer	0.000193	0.000935	CcSEcCtD
Cyclophosphamide—Oedema—Cisplatin—esophageal cancer	0.000193	0.000935	CcSEcCtD
Cyclophosphamide—Visual impairment—Capecitabine—esophageal cancer	0.000193	0.000935	CcSEcCtD
Cyclophosphamide—Infection—Cisplatin—esophageal cancer	0.000191	0.000929	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Capecitabine—esophageal cancer	0.000189	0.000917	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000189	0.000916	CcSEcCtD
Cyclophosphamide—Tachycardia—Cisplatin—esophageal cancer	0.000188	0.000913	CcSEcCtD
Cyclophosphamide—Tinnitus—Capecitabine—esophageal cancer	0.000186	0.000905	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Cisplatin—esophageal cancer	0.000186	0.000904	CcSEcCtD
Cyclophosphamide—Flushing—Capecitabine—esophageal cancer	0.000186	0.000901	CcSEcCtD
Cyclophosphamide—Anorexia—Cisplatin—esophageal cancer	0.000184	0.000891	CcSEcCtD
Cyclophosphamide—Hypotension—Cisplatin—esophageal cancer	0.00018	0.000874	CcSEcCtD
Cyclophosphamide—Chills—Capecitabine—esophageal cancer	0.000179	0.000871	CcSEcCtD
Cyclophosphamide—Arrhythmia—Capecitabine—esophageal cancer	0.000179	0.000867	CcSEcCtD
Cyclophosphamide—Abdominal discomfort—Methotrexate—esophageal cancer	0.000178	0.000865	CcSEcCtD
Cyclophosphamide—Alopecia—Capecitabine—esophageal cancer	0.000177	0.000857	CcSEcCtD
Cyclophosphamide—Pancytopenia—Methotrexate—esophageal cancer	0.000177	0.000857	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000176	0.000852	CcSEcCtD
Cyclophosphamide—Erythema—Capecitabine—esophageal cancer	0.000174	0.000845	CcSEcCtD
Cyclophosphamide—Paraesthesia—Cisplatin—esophageal cancer	0.000173	0.00084	CcSEcCtD
Cyclophosphamide—Dyspnoea—Cisplatin—esophageal cancer	0.000172	0.000834	CcSEcCtD
Cyclophosphamide—Dysgeusia—Capecitabine—esophageal cancer	0.00017	0.000827	CcSEcCtD
Cyclophosphamide—Decreased appetite—Cisplatin—esophageal cancer	0.000167	0.000813	CcSEcCtD
Cyclophosphamide—Muscle spasms—Capecitabine—esophageal cancer	0.000167	0.000812	CcSEcCtD
Cyclophosphamide—Pneumonia—Methotrexate—esophageal cancer	0.000167	0.000809	CcSEcCtD
Cyclophosphamide—Pain—Cisplatin—esophageal cancer	0.000165	0.0008	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000164	0.000798	CcSEcCtD
Cyclophosphamide—Vision blurred—Capecitabine—esophageal cancer	0.000164	0.000796	CcSEcCtD
Cyclophosphamide—Tremor—Capecitabine—esophageal cancer	0.000163	0.000791	CcSEcCtD
Cyclophosphamide—Renal failure—Methotrexate—esophageal cancer	0.000163	0.000791	CcSEcCtD
Cyclophosphamide—Stomatitis—Methotrexate—esophageal cancer	0.000162	0.000784	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Capecitabine—esophageal cancer	0.000161	0.000784	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Methotrexate—esophageal cancer	0.000161	0.000782	CcSEcCtD
Cyclophosphamide—Anaemia—Capecitabine—esophageal cancer	0.000161	0.000781	CcSEcCtD
Cyclophosphamide—Sweating—Methotrexate—esophageal cancer	0.000159	0.000771	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Cisplatin—esophageal cancer	0.000159	0.000771	CcSEcCtD
Cyclophosphamide—Haematuria—Methotrexate—esophageal cancer	0.000158	0.000767	CcSEcCtD
Cyclophosphamide—Malaise—Capecitabine—esophageal cancer	0.000157	0.000762	CcSEcCtD
Cyclophosphamide—Leukopenia—Capecitabine—esophageal cancer	0.000156	0.000756	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Methotrexate—esophageal cancer	0.000155	0.000751	CcSEcCtD
Cyclophosphamide—Palpitations—Capecitabine—esophageal cancer	0.000154	0.000746	CcSEcCtD
Cyclophosphamide—Body temperature increased—Cisplatin—esophageal cancer	0.000152	0.000739	CcSEcCtD
Cyclophosphamide—Cough—Capecitabine—esophageal cancer	0.000152	0.000737	CcSEcCtD
Cyclophosphamide—Hypertension—Capecitabine—esophageal cancer	0.00015	0.000729	CcSEcCtD
Cyclophosphamide—Haemoglobin—Methotrexate—esophageal cancer	0.00015	0.000726	CcSEcCtD
Cyclophosphamide—Haemorrhage—Methotrexate—esophageal cancer	0.000149	0.000722	CcSEcCtD
Cyclophosphamide—Hepatitis—Methotrexate—esophageal cancer	0.000149	0.000722	CcSEcCtD
Cyclophosphamide—Arthralgia—Capecitabine—esophageal cancer	0.000148	0.000719	CcSEcCtD
Cyclophosphamide—Chest pain—Capecitabine—esophageal cancer	0.000148	0.000719	CcSEcCtD
Cyclophosphamide—Myalgia—Capecitabine—esophageal cancer	0.000148	0.000719	CcSEcCtD
Cyclophosphamide—Discomfort—Capecitabine—esophageal cancer	0.000146	0.000711	CcSEcCtD
Cyclophosphamide—Visual impairment—Methotrexate—esophageal cancer	0.000143	0.000696	CcSEcCtD
Cyclophosphamide—Confusional state—Capecitabine—esophageal cancer	0.000143	0.000695	CcSEcCtD
Cyclophosphamide—Oedema—Capecitabine—esophageal cancer	0.000142	0.000689	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Cisplatin—esophageal cancer	0.000142	0.000689	CcSEcCtD
Cyclophosphamide—Infection—Capecitabine—esophageal cancer	0.000141	0.000685	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Methotrexate—esophageal cancer	0.000141	0.000683	CcSEcCtD
Cyclophosphamide—Shock—Capecitabine—esophageal cancer	0.00014	0.000678	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Capecitabine—esophageal cancer	0.000139	0.000675	CcSEcCtD
Cyclophosphamide—Tinnitus—Methotrexate—esophageal cancer	0.000139	0.000674	CcSEcCtD
Cyclophosphamide—Tachycardia—Capecitabine—esophageal cancer	0.000139	0.000673	CcSEcCtD
Cyclophosphamide—Asthenia—Cisplatin—esophageal cancer	0.000138	0.000671	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Capecitabine—esophageal cancer	0.000137	0.000666	CcSEcCtD
Cyclophosphamide—Anorexia—Capecitabine—esophageal cancer	0.000135	0.000657	CcSEcCtD
Cyclophosphamide—Chills—Methotrexate—esophageal cancer	0.000134	0.000648	CcSEcCtD
Cyclophosphamide—Hypotension—Capecitabine—esophageal cancer	0.000133	0.000644	CcSEcCtD
Cyclophosphamide—Diarrhoea—Cisplatin—esophageal cancer	0.000132	0.00064	CcSEcCtD
Cyclophosphamide—Alopecia—Methotrexate—esophageal cancer	0.000131	0.000638	CcSEcCtD
Cyclophosphamide—Erythema—Methotrexate—esophageal cancer	0.00013	0.000629	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000129	0.000628	CcSEcCtD
Cyclophosphamide—Paraesthesia—Capecitabine—esophageal cancer	0.000128	0.000619	CcSEcCtD
Cyclophosphamide—Dysgeusia—Methotrexate—esophageal cancer	0.000127	0.000616	CcSEcCtD
Cyclophosphamide—Dyspnoea—Capecitabine—esophageal cancer	0.000127	0.000615	CcSEcCtD
Cyclophosphamide—Decreased appetite—Capecitabine—esophageal cancer	0.000123	0.000599	CcSEcCtD
Cyclophosphamide—Vomiting—Cisplatin—esophageal cancer	0.000122	0.000595	CcSEcCtD
Cyclophosphamide—Fatigue—Capecitabine—esophageal cancer	0.000122	0.000594	CcSEcCtD
Cyclophosphamide—Vision blurred—Methotrexate—esophageal cancer	0.000122	0.000593	CcSEcCtD
Cyclophosphamide—Rash—Cisplatin—esophageal cancer	0.000121	0.00059	CcSEcCtD
Cyclophosphamide—Constipation—Capecitabine—esophageal cancer	0.000121	0.00059	CcSEcCtD
Cyclophosphamide—Pain—Capecitabine—esophageal cancer	0.000121	0.00059	CcSEcCtD
Cyclophosphamide—Dermatitis—Cisplatin—esophageal cancer	0.000121	0.000589	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Methotrexate—esophageal cancer	0.00012	0.000583	CcSEcCtD
Cyclophosphamide—Anaemia—Methotrexate—esophageal cancer	0.00012	0.000581	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Capecitabine—esophageal cancer	0.000117	0.000568	CcSEcCtD
Cyclophosphamide—Malaise—Methotrexate—esophageal cancer	0.000117	0.000567	CcSEcCtD
Cyclophosphamide—Leukopenia—Methotrexate—esophageal cancer	0.000116	0.000563	CcSEcCtD
Cyclophosphamide—Nausea—Cisplatin—esophageal cancer	0.000114	0.000556	CcSEcCtD
Cyclophosphamide—Cough—Methotrexate—esophageal cancer	0.000113	0.000549	CcSEcCtD
Cyclophosphamide—Urticaria—Capecitabine—esophageal cancer	0.000113	0.000548	CcSEcCtD
Cyclophosphamide—Body temperature increased—Capecitabine—esophageal cancer	0.000112	0.000545	CcSEcCtD
Cyclophosphamide—Convulsion—Methotrexate—esophageal cancer	0.000112	0.000545	CcSEcCtD
Cyclophosphamide—Arthralgia—Methotrexate—esophageal cancer	0.00011	0.000535	CcSEcCtD
Cyclophosphamide—Chest pain—Methotrexate—esophageal cancer	0.00011	0.000535	CcSEcCtD
Cyclophosphamide—Myalgia—Methotrexate—esophageal cancer	0.00011	0.000535	CcSEcCtD
Cyclophosphamide—Discomfort—Methotrexate—esophageal cancer	0.000109	0.000529	CcSEcCtD
Cyclophosphamide—Confusional state—Methotrexate—esophageal cancer	0.000107	0.000517	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Methotrexate—esophageal cancer	0.000106	0.000513	CcSEcCtD
Cyclophosphamide—Infection—Methotrexate—esophageal cancer	0.000105	0.00051	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Capecitabine—esophageal cancer	0.000105	0.000508	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Methotrexate—esophageal cancer	0.000104	0.000502	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Methotrexate—esophageal cancer	0.000102	0.000496	CcSEcCtD
Cyclophosphamide—Asthenia—Capecitabine—esophageal cancer	0.000102	0.000495	CcSEcCtD
Cyclophosphamide—Anorexia—Methotrexate—esophageal cancer	0.000101	0.000489	CcSEcCtD
Cyclophosphamide—Pruritus—Capecitabine—esophageal cancer	0.0001	0.000488	CcSEcCtD
Cyclophosphamide—Hypotension—Methotrexate—esophageal cancer	9.88e-05	0.00048	CcSEcCtD
Cyclophosphamide—Diarrhoea—Capecitabine—esophageal cancer	9.72e-05	0.000472	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	9.63e-05	0.000468	CcSEcCtD
Cyclophosphamide—Paraesthesia—Methotrexate—esophageal cancer	9.49e-05	0.000461	CcSEcCtD
Cyclophosphamide—Dyspnoea—Methotrexate—esophageal cancer	9.42e-05	0.000458	CcSEcCtD
Cyclophosphamide—Dizziness—Capecitabine—esophageal cancer	9.39e-05	0.000456	CcSEcCtD
Cyclophosphamide—Decreased appetite—Methotrexate—esophageal cancer	9.19e-05	0.000446	CcSEcCtD
Cyclophosphamide—Fatigue—Methotrexate—esophageal cancer	9.11e-05	0.000442	CcSEcCtD
Cyclophosphamide—Pain—Methotrexate—esophageal cancer	9.04e-05	0.000439	CcSEcCtD
Cyclophosphamide—Vomiting—Capecitabine—esophageal cancer	9.03e-05	0.000438	CcSEcCtD
Cyclophosphamide—Rash—Capecitabine—esophageal cancer	8.95e-05	0.000435	CcSEcCtD
Cyclophosphamide—Dermatitis—Capecitabine—esophageal cancer	8.95e-05	0.000434	CcSEcCtD
Cyclophosphamide—Headache—Capecitabine—esophageal cancer	8.9e-05	0.000432	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Methotrexate—esophageal cancer	8.71e-05	0.000423	CcSEcCtD
Cyclophosphamide—Nausea—Capecitabine—esophageal cancer	8.43e-05	0.000409	CcSEcCtD
Cyclophosphamide—Urticaria—Methotrexate—esophageal cancer	8.4e-05	0.000408	CcSEcCtD
Cyclophosphamide—Body temperature increased—Methotrexate—esophageal cancer	8.36e-05	0.000406	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Methotrexate—esophageal cancer	7.79e-05	0.000378	CcSEcCtD
Cyclophosphamide—Asthenia—Methotrexate—esophageal cancer	7.58e-05	0.000368	CcSEcCtD
Cyclophosphamide—Pruritus—Methotrexate—esophageal cancer	7.48e-05	0.000363	CcSEcCtD
Cyclophosphamide—Diarrhoea—Methotrexate—esophageal cancer	7.23e-05	0.000351	CcSEcCtD
Cyclophosphamide—Dizziness—Methotrexate—esophageal cancer	6.99e-05	0.000339	CcSEcCtD
Cyclophosphamide—Vomiting—Methotrexate—esophageal cancer	6.72e-05	0.000326	CcSEcCtD
Cyclophosphamide—Rash—Methotrexate—esophageal cancer	6.67e-05	0.000324	CcSEcCtD
Cyclophosphamide—Dermatitis—Methotrexate—esophageal cancer	6.66e-05	0.000323	CcSEcCtD
Cyclophosphamide—Headache—Methotrexate—esophageal cancer	6.62e-05	0.000322	CcSEcCtD
Cyclophosphamide—Nausea—Methotrexate—esophageal cancer	6.28e-05	0.000305	CcSEcCtD
Cyclophosphamide—CYP2C8—Metabolism—TYMP—esophageal cancer	1.85e-05	0.000175	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GAPDH—esophageal cancer	1.82e-05	0.000173	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.82e-05	0.000172	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PLCE1—esophageal cancer	1.81e-05	0.000172	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ADH7—esophageal cancer	1.81e-05	0.000172	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CRABP1—esophageal cancer	1.81e-05	0.000171	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.8e-05	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.8e-05	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ADH7—esophageal cancer	1.8e-05	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GAPDH—esophageal cancer	1.78e-05	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS1—esophageal cancer	1.78e-05	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ENO1—esophageal cancer	1.78e-05	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.78e-05	0.000168	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CRABP1—esophageal cancer	1.77e-05	0.000167	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.75e-05	0.000166	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PSME2—esophageal cancer	1.75e-05	0.000166	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PSME1—esophageal cancer	1.75e-05	0.000166	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ADH1B—esophageal cancer	1.73e-05	0.000164	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GNG7—esophageal cancer	1.72e-05	0.000163	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ADH1B—esophageal cancer	1.69e-05	0.00016	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GNG7—esophageal cancer	1.68e-05	0.000159	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.67e-05	0.000158	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—TPI1—esophageal cancer	1.67e-05	0.000158	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—TYMP—esophageal cancer	1.65e-05	0.000156	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CYP1B1—esophageal cancer	1.65e-05	0.000156	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.65e-05	0.000156	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.64e-05	0.000155	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.64e-05	0.000155	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—TYMP—esophageal cancer	1.61e-05	0.000153	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ALDH2—esophageal cancer	1.61e-05	0.000153	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.61e-05	0.000152	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.6e-05	0.000152	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ADH1B—esophageal cancer	1.59e-05	0.000151	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.58e-05	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.58e-05	0.000149	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ALDH2—esophageal cancer	1.58e-05	0.000149	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.57e-05	0.000149	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.57e-05	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CYP19A1—esophageal cancer	1.55e-05	0.000147	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.55e-05	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.54e-05	0.000146	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTT1—esophageal cancer	1.53e-05	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.53e-05	0.000145	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALOX15—esophageal cancer	1.53e-05	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—TYMP—esophageal cancer	1.52e-05	0.000144	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP2A6—esophageal cancer	1.52e-05	0.000143	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CYP1B1—esophageal cancer	1.51e-05	0.000143	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—TYMP—esophageal cancer	1.51e-05	0.000143	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTT1—esophageal cancer	1.5e-05	0.000142	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.49e-05	0.000141	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—TPI1—esophageal cancer	1.49e-05	0.000141	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP2A6—esophageal cancer	1.48e-05	0.00014	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP26A1—esophageal cancer	1.48e-05	0.00014	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.47e-05	0.000139	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—TPI1—esophageal cancer	1.46e-05	0.000138	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTO1—esophageal cancer	1.46e-05	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GNG7—esophageal cancer	1.46e-05	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.44e-05	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ENO1—esophageal cancer	1.44e-05	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.44e-05	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.43e-05	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.43e-05	0.000135	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CYP19A1—esophageal cancer	1.42e-05	0.000135	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—HMOX1—esophageal cancer	1.42e-05	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PSME2—esophageal cancer	1.42e-05	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PSME1—esophageal cancer	1.42e-05	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS1—esophageal cancer	1.4e-05	0.000133	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ENO1—esophageal cancer	1.4e-05	0.000133	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALDOB—esophageal cancer	1.4e-05	0.000132	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CA1—esophageal cancer	1.39e-05	0.000132	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.39e-05	0.000132	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PSME1—esophageal cancer	1.38e-05	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PSME2—esophageal cancer	1.38e-05	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.38e-05	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.37e-05	0.00013	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—TPI1—esophageal cancer	1.37e-05	0.00013	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CREBBP—esophageal cancer	1.37e-05	0.000129	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.37e-05	0.000129	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.36e-05	0.000129	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.36e-05	0.000129	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—TPI1—esophageal cancer	1.36e-05	0.000129	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ABCB1—esophageal cancer	1.36e-05	0.000129	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GAPDH—esophageal cancer	1.35e-05	0.000127	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.34e-05	0.000127	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CRABP1—esophageal cancer	1.33e-05	0.000126	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALDOB—esophageal cancer	1.32e-05	0.000125	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.31e-05	0.000124	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GNG7—esophageal cancer	1.3e-05	0.000123	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.3e-05	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—HMOX1—esophageal cancer	1.3e-05	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.3e-05	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.28e-05	0.000121	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.28e-05	0.000121	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CA2—esophageal cancer	1.28e-05	0.000121	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GNG7—esophageal cancer	1.27e-05	0.00012	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GAPDH—esophageal cancer	1.27e-05	0.00012	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.26e-05	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CRABP1—esophageal cancer	1.26e-05	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ABCB1—esophageal cancer	1.25e-05	0.000118	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.25e-05	0.000118	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—NOS3—esophageal cancer	1.22e-05	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.22e-05	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.22e-05	0.000115	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.22e-05	0.000115	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ENO1—esophageal cancer	1.22e-05	0.000115	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PSME2—esophageal cancer	1.2e-05	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PSME1—esophageal cancer	1.2e-05	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GNG7—esophageal cancer	1.2e-05	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.19e-05	0.000113	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALDH2—esophageal cancer	1.19e-05	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.19e-05	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ADH7—esophageal cancer	1.19e-05	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GNG7—esophageal cancer	1.19e-05	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.16e-05	0.00011	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.15e-05	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.15e-05	0.000108	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.14e-05	0.000108	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTT1—esophageal cancer	1.13e-05	0.000107	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.12e-05	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.12e-05	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTGS2—esophageal cancer	1.12e-05	0.000106	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.12e-05	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.11e-05	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ENO1—esophageal cancer	1.09e-05	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.09e-05	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PSME2—esophageal cancer	1.07e-05	0.000101	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PSME1—esophageal cancer	1.07e-05	0.000101	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.07e-05	0.000101	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ENO1—esophageal cancer	1.06e-05	0.0001	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS1—esophageal cancer	1.06e-05	0.0001	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.06e-05	0.0001	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.06e-05	0.0001	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.05e-05	9.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.05e-05	9.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.05e-05	9.91e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.04e-05	9.89e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PSME2—esophageal cancer	1.04e-05	9.89e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PSME1—esophageal cancer	1.04e-05	9.89e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.04e-05	9.85e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.04e-05	9.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.03e-05	9.79e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.02e-05	9.7e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.01e-05	9.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS1—esophageal cancer	9.99e-06	9.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ENO1—esophageal cancer	9.99e-06	9.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—TYMP—esophageal cancer	9.94e-06	9.41e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ENO1—esophageal cancer	9.9e-06	9.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS1—esophageal cancer	9.9e-06	9.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PSME2—esophageal cancer	9.84e-06	9.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PSME1—esophageal cancer	9.84e-06	9.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ABCB1—esophageal cancer	9.83e-06	9.31e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PSME2—esophageal cancer	9.75e-06	9.24e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PSME1—esophageal cancer	9.75e-06	9.24e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP19A1—esophageal cancer	9.72e-06	9.21e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	9.67e-06	9.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.42e-06	8.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.34e-06	8.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—EP300—esophageal cancer	9.31e-06	8.82e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP1B1—esophageal cancer	9.23e-06	8.74e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CREBBP—esophageal cancer	9.09e-06	8.61e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP1B1—esophageal cancer	9.01e-06	8.53e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—TPI1—esophageal cancer	8.99e-06	8.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTO1—esophageal cancer	8.99e-06	8.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—HMOX1—esophageal cancer	8.87e-06	8.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.7e-06	8.24e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP19A1—esophageal cancer	8.68e-06	8.22e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.61e-06	8.16e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.52e-06	8.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ABCB1—esophageal cancer	8.52e-06	8.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP1B1—esophageal cancer	8.49e-06	8.04e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP19A1—esophageal cancer	8.47e-06	8.02e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP1B1—esophageal cancer	8.42e-06	7.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CREBBP—esophageal cancer	8.33e-06	7.89e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.29e-06	7.85e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CRABP1—esophageal cancer	8.22e-06	7.78e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—NOS3—esophageal cancer	8.14e-06	7.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP19A1—esophageal cancer	7.98e-06	7.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—HMOX1—esophageal cancer	7.92e-06	7.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP19A1—esophageal cancer	7.91e-06	7.49e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GNG7—esophageal cancer	7.82e-06	7.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.77e-06	7.36e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—HMOX1—esophageal cancer	7.73e-06	7.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ABCB1—esophageal cancer	7.6e-06	7.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—NOS3—esophageal cancer	7.46e-06	7.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—esophageal cancer	7.44e-06	7.05e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.33e-06	6.93e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—HMOX1—esophageal cancer	7.28e-06	6.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—HMOX1—esophageal cancer	7.22e-06	6.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.08e-06	6.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ABCB1—esophageal cancer	6.99e-06	6.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTT1—esophageal cancer	6.97e-06	6.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ABCB1—esophageal cancer	6.93e-06	6.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CA—esophageal cancer	6.89e-06	6.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	6.89e-06	6.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—esophageal cancer	6.82e-06	6.46e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CREBBP—esophageal cancer	6.72e-06	6.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CREBBP—esophageal cancer	6.57e-06	6.22e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ENO1—esophageal cancer	6.53e-06	6.18e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.53e-06	6.18e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.44e-06	6.1e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PSME2—esophageal cancer	6.43e-06	6.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PSME1—esophageal cancer	6.43e-06	6.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—EP300—esophageal cancer	6.19e-06	5.86e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—NOS3—esophageal cancer	6.02e-06	5.7e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—NOS3—esophageal cancer	5.88e-06	5.57e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.75e-06	5.44e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CREBBP—esophageal cancer	5.69e-06	5.39e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—EP300—esophageal cancer	5.68e-06	5.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.55e-06	5.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—esophageal cancer	5.51e-06	5.21e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—esophageal cancer	5.38e-06	5.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.24e-06	4.96e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.22e-06	4.94e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—NOS3—esophageal cancer	5.1e-06	4.82e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CREBBP—esophageal cancer	5.08e-06	4.81e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CREBBP—esophageal cancer	4.96e-06	4.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.76e-06	4.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CREBBP—esophageal cancer	4.67e-06	4.42e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—esophageal cancer	4.66e-06	4.41e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CREBBP—esophageal cancer	4.63e-06	4.39e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CA—esophageal cancer	4.58e-06	4.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—EP300—esophageal cancer	4.58e-06	4.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.57e-06	4.33e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—NOS3—esophageal cancer	4.55e-06	4.31e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—EP300—esophageal cancer	4.48e-06	4.24e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NOS3—esophageal cancer	4.44e-06	4.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CA—esophageal cancer	4.2e-06	3.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NOS3—esophageal cancer	4.18e-06	3.96e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—esophageal cancer	4.16e-06	3.94e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NOS3—esophageal cancer	4.15e-06	3.93e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—esophageal cancer	4.06e-06	3.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—EP300—esophageal cancer	3.88e-06	3.67e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—esophageal cancer	3.83e-06	3.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.79e-06	3.59e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—EP300—esophageal cancer	3.46e-06	3.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CA—esophageal cancer	3.39e-06	3.21e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—EP300—esophageal cancer	3.38e-06	3.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CA—esophageal cancer	3.31e-06	3.13e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—EP300—esophageal cancer	3.18e-06	3.01e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—EP300—esophageal cancer	3.16e-06	2.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.06e-06	2.89e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.87e-06	2.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NOS3—esophageal cancer	2.74e-06	2.59e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CA—esophageal cancer	2.56e-06	2.42e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.5e-06	2.37e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.5e-06	2.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.35e-06	2.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.33e-06	2.21e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—EP300—esophageal cancer	2.08e-06	1.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.54e-06	1.46e-05	CbGpPWpGaD
